Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05108233

Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Thomas Jefferson University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study examines how head and neck cancer treatment affects quality of sleep over time and factors that contribute to sleep quality. Sleep plays a critical role in healing and quality of life, and recent studies investigating sleep disorders in head and neck cancer patients reveal sleep quality is a major determinant of post-treatment outcomes. Information from this study may help researchers better understand how treatment impacts sleep quality so that they can make changes that may help improve patient sleep quality.

Detailed description

PRIMARY OBJECTIVES: I. To describe the five (5) components of sleep quality in head and neck patients under different stages of post-op treatment and different environment. II. To evaluate the effect of surgery, treatment and environment on the five (5) components of sleep quality in head and neck cancer patients. SECONDARY OBJECTIVES: I. To evaluate the association between the five (5) components of sleep quality and comorbid obstructive sleep apnea (STOP-BANG and Epworth Sleeping Scale) and depression (Patient Health Questionnaire-2 \[PHQ-2\]), under different stages of post-op treatment and different environment. II. To evaluate the association between Fitbit actigraphy data (i.e. the 5th component of sleep quality) and the first 4 components of sleep quality for inpatients. III. To compare the inpatient versus the outpatient responses on sleep hygiene at different time points of measurement. EXPLORATORY OBJECTIVE: I. To assess whether survey results warrant additional counseling or patient education. OUTLINE: COHORT 1-TP1: Patients complete surveys over 20 minutes on post-op day 3 and on day of discharge (or within 1 week). COHORT 1-TP2: Patients complete surveys over 15 minutes at all regularly scheduled follow-up appointments (approximately 1 month, 3 months, 6 months, 12 months). COHORT 2: Patients complete surveys over 15 minutes once.

Conditions

Interventions

TypeNameDescription
OTHERSurvey AdministrationComplete survey

Timeline

Start date
2022-01-01
Primary completion
2024-10-24
Completion
2025-12-01
First posted
2021-11-04
Last updated
2025-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05108233. Inclusion in this directory is not an endorsement.